Formulation Development
Product Description
Genovior Biotech Corporation
-
TW -
2016On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
Categories
Specifications
Genovior Biotech Corporation
-
TW
-
2016On CPHI since
-
1Certificates
-
100 - 249Employees
Company types
Primary activities
More Products from Genovior Biotech Corporation (13)
-
Product GBC Production Plant site Video
Genovior Biotechnology Corporation facility capabilities & current ongoing production lines -
Product CDMO/CMO
Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.
Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
... -
Product CDMO/CMO 1
PFS, Lyophilization -
Product CDMO/CMO 2
PROTEIN, INJECTABLE -
Product CDMO/CMO 3
Biologic, Oncology -
Product Dedicated Oncology Production
Genovior biotech corporation offers services which includes oncology production services. It provides api: process development and production, injectables: formulation development and production of lyophilization and liquid vials, packaging and labeling. Contact us for more information. -
Product Injectables Available for Licensing
Oncology-Azacitidine, Bortezomib, Gemcitabine, Pemetrexed, Fulvestrant Peptide-Teriparatide, Glucagon, Octreotide Acetate, Terlipressin Acetate,Biologic, Others -
Product Interview by Newsweek, time to talk
Interviewee：Dr. Steve J.P. Hsu (President of Genovior Biotech) -
Product out licensing and supply
( * Manufacturing of API for in-house use)ONCOLOGY
Azacitidine*
Bortezomib*
Bendamustine*
Carboplatin
Carfilzomib*
Docetaxel
Epriubicin
Fulvestrant*
... -
Product PIPELINE AVAILABLE FOR OUR LICENSING AND SUPPLY
Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.
Our services include:
1. Process Development
2. Formulation Development
3. Analytical Deve... -
Product Process Development
1. Upstream process development
2. Downstream process development
3. Peptide APIs synthesis platform
4. Small molecule drugs synthesis platform
-
Product Regulatory Affairs
Global regulatory support
Genovior Biotech Corporation resources (7)
-
News Interview by Newsweek, Time to Talk
An interview with Dr. Steve J.P. Hsu, President of Genovior Biotech. -
Brochure Interview by Newsweek, Time to Talk
Interviewee：Dr. Steve J. P. Hsu (President of Genovior Biotech) -
Brochure
CDMO -
Video COMPANY PRESENTATION
Genovior is a dedicated CMO/CDMO, focusing on providing clients excellent, efficient, one stop services and solutions, from clinical trials (IND/NDA) to commercialization.
Our services include:
1. Process Development
2. Formulation Development
3. Analytical Development
4. Small Scale Biologics / Injectable Production
5. Commercial Scale Injectable Production
6. Dedicated Oncology Production (API / Injectables)
7. Regulatory Affairs
Generic/Peptide/Biosimilar projects available for out-licensing
Oncology-Azacitidine, Bortezomib, Pemetrexed, Fulvestrant
Peptide-Glucagon, Teriparatide, Octreotide, Terlipressin
Biosimilar-Liraglutide, Ranibizumab, Denosumab
Others-Levetiracetam, Palonosetron, Valproate
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance